Close Menu

Firefly BioWorks

Abcam was encouraged to buy Firefly BioWorks by its customers, who are more frequently complementing their protein analysis work with miRNA studies.

The all-cash deal gives Abcam access to Firefly's multiplex assay biomarker-detection platform.

NEW YORK (GenomeWeb) – Firefly BioWorks said in a document filed with the US Securities and Exchange Commission that it has raised $775,000 toward a targeted amount of $1.5 million.

Lawrence Livermore National Security and The University of California have been awarded US Patent No.

The Spanish Scientific Research Council of Madrid, Spain, has received US Patent No.

NEW YORK (GenomeWeb News) – EMD Millipore, a division of Germany's Merck KGaA, announced this week that it has signed a deal to become the global distributor of Firefly BioWorks' SmartRNAplex microRNA profiling assay.
Specific terms of the deal were not disclosed.

Firefly BioWorks said this week that it has awarded $120,000 in grant funding to support 12 projects that involve the profiling of large numbers of samples over multiple microRNA targets.

Firefly Bioworks said this week that it has established a grant program designed to support microRNA research by a scientist or engineer from any academic or non-profit research institution.

This week, Firefly BioWorks released PubmiR, a free search engine for microRNA pathways.

New Products: Firefly's PubmiR

Premium

Firefly Bioworks has released PubmiR, a search engine specifically dedicated to microRNA pathways.

Pages

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.